Received May 21, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
I had developed internal shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of zoster sine herpete in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingles vaccine (received first dose of Shingles vaccine). On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, 4 days after receiving Shingles vaccine, the patient experienced zoster sine herpete (Verbatim: I had developed internal shingles). The outcome of the zoster sine herpete was not reported. It was unknown if the reporter considered the zoster sine herpete to be related to Shingles vaccine. It was unknown if the company considered the zoster sine herpete to be related to Shingles vaccine. Additional Information: GSK Receipt Date:16-MAY-2026 and 17-MAY-2026 This case was reported by a patient via interactive digital media. The patient wanted to avoid getting shingles, especially on the face, so they opted to get the shots. The patient had received both doses of the shingles vaccine, and in the same week as the second dose, the patient developed internal Shingles. The patient had received the second dose on Monday, and by Friday, they had internal Shingles pain. The batch number was not provided and we unable to contact the reporter.